India's indigenous vaccine Covaxin from Bharat Biotech cleared for phase III trials

▴ India's indigenous vaccine Covaxin from Bharat Biotech cleared for phase III trials
Bharat Biotech's Covaxin could be the first vaccine to hit the market

In a huge boost to India's indigenous vaccine plan, Bharat Biotech has been given clearance for phase three trials in India. Covaxin's third phase trials will start in the first week of November.

Under the Phase 3 trial, the vaccine will be administered to 22 thousand people across 19 places. The government aims to vaccinate 20 to 25 crore people between January and July next year.

The government has also sought a list of all those who will be given the vaccine. Initially, the vaccine will be given on a priority basis. It is to be noted that India manufacturers around 60% of vaccine supply worldwide.

The focused efforts of Centre and State/UT governments on effective clinical management of the hospitalized cases have ensured that India’s Fatality Rate has touched 1.5%. Less than 500 deaths (480) have been reported in the last 24 hours in the country. India has one of the lowest fatality rates in the world. The Case Fatality rate is lowest since 22nd March and is continuously declining. 2218 Dedicated COVID Hospitals are providing quality medical care. At the ground level, frontline health workers like ASHAs and ANMs have done a commendable job of managing the migrant population and to enhance awareness at the community level.

As a result, there are 14 States and UTs with CFR lower than 1%.59,105 new recoveries were added in the last 24 hour whereas new recovered cases were 45,148. With this, the total number of recoveries have crossed 71 Lakh (71,37,228). A higher number of single-day recoveries is also reflected in the continuous increase in the national recovery rate, which is at present 90.23%. India continues to report a trend of steadily decreasing active cases.

Presently the active cases comprise merely 8.26% of the total positive cases of the country standing at 6,53,717. This is the lowest since 13th August when the active cases were 6,53,622. 78% of the new recovered cases are observed to be concentrated in 10 States/UTs. Karnataka has contributed the maximum to the single-day recoveries with more than 10,000 cases followed by Kerala with more than 7,000 cases. 45,148 new confirmed cases were registered in the last 24 hours in the country.

This is the lowest since 22nd July when 37,000 new cases were added. 82% of new confirmed cases are from 10 States and UTs. Kerala and Maharashtra contribute maximum to the new confirmed cases with more than 6,000 cases each followed by Karnataka, Delhi and West Bengal with more than 4,000 cases. 480 case fatalities have been reported in the past 24 hours. Of these, nearly 80% are concentrated in ten States/UTs. More than 23% of new fatalities reported are from Maharashtra (112 deaths).

Tags : #Covaxin #BharatBiotech #CovidVaccineNewsOct27 #IndiaCovidNewsOct27 #IndiaCaseFatalityRateOct27

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024